Department of Medicine & Surgery, Unit of Pathology, University of Parma, Italy (D.C., R. Monaco, R. Manuguerra).
Beth Israel Deaconess Medical Center & Harvard Medical School, Boston, MA (J.E.S., A. Asimaki).
Circ Arrhythm Electrophysiol. 2020 Aug;13(8):e008382. doi: 10.1161/CIRCEP.120.008382. Epub 2020 Jul 12.
Postoperative atrial fibrillation (POAF) occurs in 30% to 50% of patients undergoing cardiac surgery and is associated with increased morbidity and mortality. Prospective identification of structural/molecular changes in atrial myocardium that correlate with myocardial injury and precede and predict risk of POAF may identify new molecular pathways and targets for prevention of this common morbid complication.
Right atrial appendage samples were prospectively collected during cardiac surgery from 239 patients enrolled in the OPERA trial (Omega-3 Fatty Acids for Prevention of Post-Operative Atrial Fibrillation), fixed in 10% buffered formalin, and embedded in paraffin for histology. We assessed general tissue morphology, cardiomyocyte diameters, myocytolysis (perinuclear myofibril loss), accumulation of perinuclear glycogen, interstitial fibrosis, and myocardial gap junction distribution. We also assayed NT-proBNP (N-terminal pro-B-type natriuretic peptide), hs-cTnT, CRP (C-reactive protein), and circulating oxidative stress biomarkers (F2-isoprostanes, F3-isoprostanes, isofurans) in plasma collected before, during, and 48 hours after surgery. POAF was defined as occurrence of postcardiac surgery atrial fibrillation or flutter of at least 30 seconds duration confirmed by rhythm strip or 12-lead ECG. The follow-up period for all arrhythmias was from surgery until hospital discharge or postoperative day 10.
Thirty-five percent of patients experienced POAF. Compared with the non-POAF group, they were slightly older and more likely to have chronic obstructive pulmonary disease or heart failure. They also had a higher European System for Cardiac Operative Risk Evaluation and more often underwent valve surgery. No differences in left atrial size were observed between patients with POAF and patients without POAF. The extent of atrial interstitial fibrosis, cardiomyocyte myocytolysis, cardiomyocyte diameter, glycogen score or Cx43 distribution at the time of surgery was not significantly associated with incidence of POAF. None of these histopathologic abnormalities were correlated with levels of NT-proBNP, hs-cTnT, CRP, or oxidative stress biomarkers.
In sinus rhythm patients undergoing cardiac surgery, histopathologic changes in the right atrial appendage do not predict POAF. They also do not correlate with biomarkers of cardiac function, inflammation, and oxidative stress. Graphic Abstract: A graphic abstract is available for this article.
心脏手术后 30%至 50%的患者会发生心房颤动(POAF),并伴有发病率和死亡率的增加。前瞻性识别与心肌损伤相关并先于和预测 POAF 风险的心房心肌结构/分子变化,可能会发现新的分子途径和预防这种常见并发症的靶点。
在 OPERA 试验(ω-3 脂肪酸预防术后心房颤动)中,前瞻性地从 239 名接受心脏手术的患者中采集右心耳样本,用 10%缓冲福尔马林固定,石蜡包埋进行组织学检查。我们评估了组织形态、心肌细胞直径、肌溶解(核周肌原纤维丢失)、核周糖原蓄积、间质纤维化和心肌缝隙连接分布。还测定了手术前、手术中和手术后 48 小时采集的血浆中的 NT-proBNP(氨基末端 B 型利钠肽前体)、hs-cTnT(高敏肌钙蛋白 T)、CRP(C 反应蛋白)和循环氧化应激生物标志物(F2-异前列腺素、F3-异前列腺素、异呋喃)。POAF 定义为通过节律带或 12 导联心电图证实的术后心房颤动或颤动至少 30 秒的发生。所有心律失常的随访时间从手术开始到出院或术后第 10 天。
35%的患者发生 POAF。与非 POAF 组相比,他们年龄稍大,更有可能患有慢性阻塞性肺疾病或心力衰竭。他们的欧洲心脏手术风险评估系统评分也更高,更常进行瓣膜手术。POAF 患者与无 POAF 患者的左心房大小无差异。手术时心房间质纤维化、心肌细胞肌溶解、心肌细胞直径、糖原评分或 Cx43 分布程度与 POAF 的发生率无显著相关性。这些组织病理学异常均与 NT-proBNP、hs-cTnT、CRP 或氧化应激生物标志物水平无关。
在窦性心律患者接受心脏手术时,右心耳的组织病理学改变不能预测 POAF。它们也与心脏功能、炎症和氧化应激的生物标志物无关。